H
Humedica
Real world data. Actionable insights. Confident decision-making. #Humedica, #clinicalanalytics, #populationhealth
About Humedica
Founded in 2008, Humedica emerged as a trailblazer in the realm of clinical intelligence, providing cloud-based analytics solutions tailored for the healthcare industry. The company was the brainchild of Michael Weintraub, who envisioned a platform that could harness the power of data to improve healthcare outcomes.
Humedica's innovative approach involved assembling, standardizing, and analyzing electronic health records and financial data, offering healthcare providers actionable insights to enhance patient care. This unique value proposition quickly attracted attention, leading to significant investments from notable entities like Merck and Allscripts.
In a pivotal moment for the company, Humedica was acquired by UnitedHealth Group's Optum division in January 2013. The acquisition, reportedly valued at hundreds of millions of dollars, underscored the strategic importance of data analytics in healthcare and marked a significant milestone in Humedica's journey.
Through this acquisition, Humedica's capabilities were integrated into Optum's broader suite of healthcare services, amplifying its impact and reach. This move not only validated Humedica's business model but also highlighted the growing demand for sophisticated data solutions in the healthcare sector. Today, Humedica's legacy continues to influence the industry, setting a benchmark for clinical intelligence and data-driven healthcare solutions.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1979
- Headquarters
- Boston, United States
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 75.3/100
- Industry
- Health, Enterprise Software
- Sector
- Health, Risk Management, Analytics, Oncology
- Technology
- Big Data, Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| FundingOther financing | Jun 2013 | $0 | — | Undisclosed | ↗ |
| ACQUISITIONOther financing | Jan 2013 | $0 | — | UnitedHealth Group | — |
Growth signals
Latest recorded traffic for Humedica is 0 monthly website visits. Humedica's team grew 5.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Bain Capital Ventures
Veradigm (Allscripts Healthcare Solutions)
West Health Investment Fund
The Kraft Group
Other known investors1 additional known investor
UnitedHealth Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Humedica on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Humedica’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.